Evidence map›Paper›PMID 32243126›Full record

ArticleACS infectious diseases2020

Switchable Membrane Remodeling and Antifungal Defense by Metamorphic Chemokine XCL1.

Acacia F Dishman, Michelle W Lee, Jaime de Anda, Ernest Y Lee, Jie He, Anna R Huppler, Gerard C L Wong, Brian F Volkman

Open access · bronzeAbstract read
In one paragraph

Article in ACS infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Fold-Switching Proteins.Annual review of biophysics · 2026
    Review
  2. Article
  3. Review
  4. The multifaceted role of XCL1 in health and disease.Protein science : a publication of the Protein Society · 2025
    Review
  5. Design and discovery of metamorphic proteins.Current opinion in structural biology · 2022
    Review
  6. Article
  7. Metamorphic Protein Folding Encodes Multiple Anti-Pathogens (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. Plant Defensins from a Structural Perspective.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Acacia F DishmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States.ORCID 0000-0002-8952-8551
Michelle W LeeDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0003-1613-9501
Jaime de AndaDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0003-2129-0775
Ernest Y LeeDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, California 90095, United States.ORCID 0000-0001-5144-2552
Jie HeDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States.
Anna R HupplerDepartment of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States.
Gerard C L WongDepartment of Bioengineering, University of California, Los Angeles, Los Angeles, California 90095, United States.
Brian F VolkmanDepartment of Biochemistry, Medical College of Wisconsin, Milwaukee, Wisconsin 53226 United States.ORCID 0000-0002-6681-5179
Medical College of Wisconsin · USUniversity of California, Los Angeles · USCalifornia Institute of Technology · US

Funding

UCLA-Caltech Medical Scientist Training ProgramT32GM008042 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI AJIJOLA, OLUJIMI A, DAWSON, DAVID WAYNE · 1985 to 2023
$29.9M
Medical Scientist Training ProgramT32GM080202 · NIGMS · MEDICAL COLLEGE OF WISCONSIN · PI BARBIERI, JOSEPH T, SALZMAN, NITA H · 2010 to 2024
$5.7M
Cathelicidins in Skin ImmunityR01AI052453 · NIAID · VETERANS MEDICAL RESEARCH FDN/SAN DIEGO · PI GALLO, RICHARD L, NIZET, VICTOR · 2002 to 2017
$5.3M
Systems in Integrative BiologyT32GM008185 · NIGMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CHOU, TOM · 1987 to 2022
$4.6M
Structural Basis for Chemokine FunctionR01AI058072 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2004 to 2019
$4.1M
Surface sensing, memory, and motility control in biofilm formationR01AI143730 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI O'TOOLE, GEORGE A., WONG, GERARD C · 2019 to 2023
$2.0M
Targeting CCL28 as therapy for obstructive lung diseaseR01AI120655 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI VOLKMAN, BRIAN F · 2015 to 2018
$1.5M
Dermatology Scientist Training ProgramT32AR071307 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MODLIN, ROBERT L · 2017 to 2021
$1.1M
Anti-Candida activity of CCL28 in oropharyngeal candidiasisK08DE026189 · NIDCR · MEDICAL COLLEGE OF WISCONSIN · PI HUPPLER, ANNA · 2017 to 2021
$860k
Structure-Function Investigation of Chemokine-GPCR Signaling in Tumor Progression and MetastasisF30CA236182 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI DISHMAN, ACACIA F · 2019 to 2023
$242k
NCI NIH HHS F30 CA236182NIAID NIH HHS R01 AI052453NIAID NIH HHS R01 AI058072NIAID NIH HHS R01 AI120655NIAID NIH HHS R01 AI143730NIAMS NIH HHS T32 AR071307NIDCR NIH HHS K08 DE026189NIGMS NIH HHS T32 GM008042NIGMS NIH HHS T32 GM008185NIGMS NIH HHS T32 GM080202
6 · The paper itself

Abstract

Antimicrobial peptides (AMPs) are a class of molecules which generally kill pathogens via preferential cell membrane disruption. Chemokines are a family of signaling proteins that direct immune cell migration and share a conserved α-β tertiary structure. Recently, it was found that a subset of chemokines can also function as AMPs, including CCL20, CXCL4, and XCL1. It is therefore surprising that machine learning based analysis predicts that CCL20 and CXCL4's α-helices are membrane disruptive, while XCL1's helix is not. XCL1, however, is the only chemokine known to be a metamorphic protein which can interconvert reversibly between two distinct native structures (a β-sheet dimer and the α-β chemokine structure). Here, we investigate XCL1's antimicrobial mechanism of action with a focus on the role of metamorphic folding. We demonstrate that XCL1 is a molecular "Swiss army knife" that can refold into different structures for distinct context-dependent functions: whereas the α-β chemokine structure controls cell migration by binding to G-Protein Coupled Receptors (GPCRs), we find using small angle X-ray scattering (SAXS) that only the β-sheet and unfolded XCL1 structures can induce negative Gaussian curvature (NGC) in membranes, the type of curvature topologically required for membrane permeation. Moreover, the membrane remodeling activity of XCL1's β-sheet structure is strongly dependent on membrane composition: XCL1 selectively remodels bacterial model membranes but not mammalian model membranes. Interestingly, XCL1 also permeates fungal model membranes and exhibits anti-

Indexed as

Cell MembraneCandidaChemokines, CPore Forming Cytotoxic ProteinsProtein FoldingProtein Structure, SecondaryScattering, Small AngleX-Ray DiffractionChemokines, CPore Forming Cytotoxic Proteinsantifungalantimicrobialchemokinesmetamorphic proteinssmall-angle X-ray scatteringXCL1

Identifiers

PMID32243126
PMCPMC7258946
OpenAlexW3014279392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.